Cargando…

Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers

Easily accessible biomarkers are urgently needed to evaluate immune activation in Juvenile Dermatomyositis (JDM). The goal of this retrospective study is to define immunological and clinical differences between untreated JDM patients with either normal or elevated (>10 mmol/L) levels of neopterin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khojah, Amer, Morgan, Gabrielle, Pachman, Lauren M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774344/ https://www.ncbi.nlm.nih.gov/pubmed/35054173 http://dx.doi.org/10.3390/diagnostics12010008

Ejemplares similares

Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy
por: Pachman, Lauren M., et al.
Publicado: (2021)

The von Willebrand Factor Antigen Reflects the Juvenile Dermatomyositis Disease Activity Score
por: Gibbs, Ellie, et al.
Publicado: (2023)

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
por: Pachman, Lauren M., et al.
Publicado: (2023)

Juvenile Dermatomyositis: Association between Nail Fold Capillary End Row Loops Area Under the Curve and Disease Damage Indicators
por: Khojah, Amer, et al.
Publicado: (2023)

Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators
por: Khojah, Amer, et al.
Publicado: (2023)

B Cell Lymphocytosis in Juvenile Dermatomyositis
por: Costin, Christopher, et al.
Publicado: (2023)

Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
por: Costin, Christopher, et al.
Publicado: (2023)

Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids
por: Khojah, Amer, et al.
Publicado: (2021)

Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study
por: Ochfeld, Elisa, et al.
Publicado: (2022)

Serum protein biomarkers for juvenile dermatomyositis: a pilot study
por: Tawalbeh, Shefa M., et al.
Publicado: (2020)

Increased Otoferlin Expression in B Cells Is Associated with Muscle Weakness in Untreated Juvenile Dermatomyositis: A Pilot Study
por: Bukhari, Ameera, et al.
Publicado: (2023)

Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study
por: Xu, Dong, et al.
Publicado: (2017)

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
por: Duvvuri, Bhargavi, et al.
Publicado: (2023)

Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive
por: Roberson, Elisha D. O., et al.
Publicado: (2022)

Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis
por: Conklin, Laurie S., et al.
Publicado: (2018)

Serum Neopterin Is Not Increased in Obese Juveniles
por: Mangge, Harald, et al.
Publicado: (2011)

Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis
por: Chen, Yi-Wen, et al.
Publicado: (2008)

Decreased CD3-CD16+CD56+ natural killer cell counts in children with orbital myositis: a clue to disease activity
por: Briones, Melissa R, et al.
Publicado: (2017)

Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis—Insights From Other Diseases
por: Hoeppli, Romy E., et al.
Publicado: (2019)

Neopterin: Biomarker of cell-mediated immunity and potent usage as biomarker in silicosis and other occupational diseases
por: Pingle, Shubhangi K., et al.
Publicado: (2008)

Comparison between plasma neopterin and the urine neopterin:creatinine ratio as inflammatory biomarkers
por: Thomas, Bianca, et al.
Publicado: (2019)

Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis
por: Wienke, Judith, et al.
Publicado: (2020)

Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseases
por: Molero-Luis, Marta, et al.
Publicado: (2020)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

Dyslipidemia in active juvenile dermatomyositis patients
por: Kozu, KT, et al.
Publicado: (2011)

Juvenile Dermatomyositis in Pregnancy
por: Madu, Anthony Emeka, et al.
Publicado: (2013)

The Vasculopathy of Juvenile Dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2018)

Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis
por: Castillo, Rochelle L., et al.
Publicado: (2021)

Assessment of Serum Neopterin as a Biomarker in Peripheral Artery Disease
por: Zembron-Lacny, Agnieszka, et al.
Publicado: (2021)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult Dermatomyositis
por: Crowson, Cynthia S., et al.
Publicado: (2019)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

Juvenile Dermatomyositis—Clinical Phenotypes
por: Li, Danyang, et al.
Publicado: (2019)

Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)

A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies
por: Martin, Neil, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fvpmp0q7d58snfrc7jp58pf5d5